Effect of Raloxifene on All-cause Mortality
Authors:
- Deborah GradyDGDeborah Grady
- Jane A. CauleyJCJane A. Cauley
- John L. StockJSJohn L. Stock
- David A. CoxDCDavid A. Cox
- Bruce H. MitlakBMBruce H. Mitlak
- Jingli SongJSJingli Song
- Steven R. CummingsSCSteven R. Cummings
- 1 May 2010
- journal article
- research article
- Published by Elsevier in The American Journal of Medicine
- Vol. 123 (5) , 469.e1-469.e7
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Effect of Raloxifene on Stroke and Venous Thromboembolism According to Subgroups in Postmenopausal Women at Increased Risk of Coronary Heart DiseaseStroke, 2009
- Reduced Incidence of Invasive Breast Cancer With Raloxifene Among Women at Increased Coronary RiskJNCI: Journal of the National Cancer Institute, 2008
- Effects of Raloxifene on Cardiovascular Events and Breast Cancer in Postmenopausal WomenNew England Journal of Medicine, 2006
- Continuing Outcomes Relevant to Evista: Breast Cancer Incidence in Postmenopausal Osteoporotic Women in a Randomized Trial of RaloxifeneJNCI: Journal of the National Cancer Institute, 2004
- Safety and Adverse Effects Associated With Raloxifene: Multiple Outcomes of Raloxifene EvaluationObstetrics & Gynecology, 2004
- Efficacy of Raloxifene on Vertebral Fracture Risk Reduction in Postmenopausal Women with Osteoporosis: Four-Year Results from a Randomized Clinical TrialThe Journal of Clinical Endocrinology & Metabolism, 2002
- Continued Breast Cancer Risk Reduction in Postmenopausal Women Treated with Raloxifene: 4-Year Results from the MORE TrialBreast Cancer Research and Treatment, 2001
- Reduction of Vertebral Fracture Risk in Postmenopausal Women With Osteoporosis Treated With RaloxifeneResults From a 3-Year Randomized Clinical TrialJAMA, 1999
- The Effect of Raloxifene on Risk of Breast Cancer in Postmenopausal WomenJAMA, 1999
- Effects of Raloxifene on Serum Lipids and Coagulation Factors in Healthy Postmenopausal WomenJAMA, 1998